Let's hope that they are using this method:
"Monoclonal antibodies (mAbs) hold great promise for treating diseases ranging from cancer to infectious disease. Manufacture of mAbs is challenging, expensive, and time-consuming using mammalian systems. We describe detailed methods used by Kentucky BioProcessing (KBP), a subsidiary of British American Tobacco, for producing high quality mAbs in a Nicotiana benthamiana host. Using this process, mAbs that meet GMP standards can be produced in as little as 10 days."
https://www.sciencedirect.com/science/article/abs/pii/S0076687921001932
...but let's face it, they're probably using a time-consuming mammalian - sporadic inducing - system....
Let's hope that they are using this method:"Monoclonal...
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.46M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.8¢ | $9.338K | 1.167M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 103590 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 300000 | 1 |
View Market Depth
| Last trade - 15.05pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.8¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.8¢ | 0.8¢ | 0.8¢ | 266501 | ||
| Last updated 15.05pm 03/05/2024 ? | |||||
| PAB (ASX) Chart |